Cotton ... agree, waiting on pins & needles also for some news or leaks. However, a few early initial data points can be misleading to the positive or negative, or may even be detrimental to company strategic goals depending on the data and those goals. From the company POV, better to understand what is happening and how it is going, and organize an intelligent approach to next goals/steps.

Also, do we even have any idea whatsoever how many locations are actually recruiting/dosing, and how many patients so far??

Personally, my next inflection point timing is May:

1. Should be plenty of time to recruit/dose, and see/explain some results ... show me the beef? and pps/money?

2. Debenture ... how is this going to be resolved, and to what end or display of confidence on each end? There will have to be either a payment, a new financing, or a deal of some kind?

3. Targeted/expected EUA application timing ... will this happen, and why or why not?

A lot of key timing and strategic happenings in May, with the debenture as a backstop for news whether overt communications or actions that will explain the current state of the company and investment. Always a chance that something good or bad can pop before then though, obviously.

Anticipation and waiting is hard.

jmho's